Healthcare

For investors in Telix Pharmaceuticals, 2026 is shaping up to be a defining period. The company’s commercial prospects hinge on...

BioNTech's stock has faced significant headwinds from founder transitions and subdued financial forecasts. However, developments within its research pipeline offer...

Eli Lilly and Company is approaching a pivotal period marked by two significant catalysts. While the pharmaceutical giant's stock has...

Danish pharmaceutical giant Novo Nordisk has achieved a landmark regulatory victory with the U.S. Food and Drug Administration (FDA) granting...

The Swiss hearing solutions group Sonova is taking decisive action to refine its business focus. By announcing the sale of...

Intuitive Surgical continues to solidify its dominant position in operating rooms worldwide. The company's latest financial results for the fourth...

The specialized packaging manufacturer Gerresheimer finds itself in a precarious position, grappling with a confluence of internal and external pressures....

Pharmaceutical giant Pfizer has announced significant progress across two distinct areas of its clinical pipeline, marking a pivotal moment in...

Bayer AG finds itself at a confluence of strategic developments, with a new flagship location, steady share price action, and...

The healthcare conglomerate Fresenius has reported a robust finish to its 2025 fiscal year, marked by significant profit growth. Despite...